Reframing hepatitis B prophylaxis in liver transplant recipients - time to focus on cure [0.03%]
肝移植受者的乙型肝炎预防再思考——是时候重视乙肝的治愈了
Norah Terrault
Norah Terrault
Safety and feasibility of duct-to-duct biliary anastomosis in pediatric liver transplantation: A single-center retrospective study [0.03%]
肝移植中儿童肝移植胆道"管对管"重建的安全性和可行性:一项单中心回顾性研究
Shiming Gong,Lijie Ma,Bingran Wang et al.
Shiming Gong et al.
Objective: The objective of this study was to assess the safety and feasibility of duct-to-duct anastomosis (DDA) in pediatric liver transplantation (PLT) with left-sided grafts. ...
Long-term outcome of the initial cases with recipient-side minimal invasive liver transplantation: Single-center comparison study [0.03%]
最小切口肝移植供受体远期效果分析：单中心对比研究
Jinsoo Rhu,Jongman Kim,Namkee Oh et al.
Jinsoo Rhu et al.
Background: Living donor liver transplantation has evolved with minimally invasive donor hepatectomy now widely adopted at leading centers. The next frontier is recipient-side minimally invasive approach, yet data remains...
Variations in liver allocation systems across continents with a focus on MELD exceptions [0.03%]
全球肝移植分配系统差异分析——以MELD例外情况为例
Tomohiro Tanaka,Abdul Rahman Hakeem,Ryan Chadha et al.
Tomohiro Tanaka et al.
Variations in liver allocation systems world-wide are presented, with a specific focus on regional differences and their potential impact on outcomes, with the goal to serve as a reference for future policy development. Summaries of liver a...
Postoperative complications after liver transplantation: Are we making progress? [0.03%]
肝移植术后的并发症：我们在进步吗？
George Therapondos,Ari J Cohen
George Therapondos
Analysis of the impact of female sex and muscle mass on serum creatinine and waitlist priority for liver transplantation [0.03%]
女性性别和肌肉量对血清肌酐及肝移植排序优先权影响的分析研究
Shivangi Gupta,Angus W Jeffrey,Zhengyi Wang et al.
Shivangi Gupta et al.
Background and aim: Model for End-Stage Liver Disease (MELD) incorporates serum creatinine (sCr), a poor measure of renal function in cirrhotic patients. Females have higher waitlist mortality which is proposed to be due ...
Optimizing liver transplant outcomes for colorectal liver metastases in the united states [0.03%]
美国结直肠肝转移肝脏移植效果的优化
Mariana Chávez-Villa,Kazunari Sasaki,Toshihiro Nakayama et al.
Mariana Chávez-Villa et al.
The TransMet trial and Norwegian studies have shown excellent outcomes in highly selected patients undergoing liver transplant (LT) for unresectable colorectal liver metastases (uCRLM). Our aim is to provide an updated analysis of the curre...
Cervical cancer screening remains low in liver transplant patients regardless of demographics: A single-center review [0.03%]
肝移植患者无论人口统计学特征如何宫颈癌筛查率仍低：单中心回顾研究
Pavithra Ramakrishnan,Jacquelin Blomker,Katherine Cooke et al.
Pavithra Ramakrishnan et al.
Safety of immunotherapy post liver transplantation- A multicentered study of a prospective standardized clinical practice protocol [0.03%]
肝移植后免疫治疗的安全性——一项多中心前瞻性标准化临床实践方案研究
Kymberly D Watt,Sanurav Panda,Valeria Pierluissi et al.
Kymberly D Watt et al.
Background: Immune checkpoint-inhibitors (ICI) have improved cancer prognosis significantly, but their use has been avoided in liver transplant recipients (LTr) due to poorly characterized rejection risk. Data surrounding...
Evolving trends and comparative outcomes of bridging transarterial locoregional therapy in liver transplant candidates with hepatocellular carcinoma [0.03%]
等待肝移植的肝细胞癌患者的过渡性动脉区域治疗的发展趋势及疗效比较分析研究
Butros Fakhoury,Vinay Jahagirdar,Marwan Alsaqa et al.
Butros Fakhoury et al.
Background: Bridging locoregional therapy (LRT) is widely used in liver transplant (LT) candidates with hepatocellular carcinoma (HCC) to minimize waitlist dropout and evaluate tumor biology. While transarterial chemoembo...